Cancer News and Research

Latest Cancer News and Research

Researchers shed light on how immune cells weaken with age

Researchers from the European Bioinformatics Institute, University of Cambridge, the Wellcome Trust Sanger Institute and the Cancer Research UK–Cambridge Institute have shed light on a long-standing debate about why the immune system weakens with age.

3 Apr 2017

RCR: NHS delivery plans fail to tackle early diagnosis, treatment of cancer

Commenting on today’s update on the NHS England Five-Year Forward view delivery plans to tackle early diagnosis and treatment of cancer, Dr Nicola Strickland, President of The Royal College of Radiologists.

3 Apr 2017

Patients' immune system profiles could be linked to effectiveness of cancer immunotherapy

Higher or lower levels of certain immune cells in cancer patients may be associated with how well they respond to immunotherapy, according to preliminary results of a study conducted by researchers at the University of Pittsburgh Cancer Institute.

3 Apr 2017

New gene-based blood tests can reliably detect previously unidentifiable forms of skin cancer

Genetic testing of tumor and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that two new blood tests can reliably detect previously unidentifiable forms of the disease.

3 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.

2 Apr 2017

Cow's milk decreases the body's ability to absorb oral thyroid hormone medication

Taking the common oral thyroid hormone medication levothyroxine with a glass of cow's milk significantly decreases the body's ability to absorb the drug, a preliminary study finds. Results will be presented Sunday at ENDO 2017, the Endocrine Society's 99th annual meeting in Orlando, Fla.

2 Apr 2017

Pyrethroid pesticide exposure may cause earlier sexual maturity in boys

Environmental exposure to common pesticides may cause boys to reach sexual maturity earlier, researchers have found. They will present their study results Saturday at the Endocrine Society's 99th annual meeting in Orlando, Fla.

2 Apr 2017

Exposure to flame retardants may be linked to papillary thyroid cancer risk

Some flame retardants used in many home products appear to be associated with the most common type of thyroid cancer, papillary thyroid cancer (PTC), according to a new study being presented Saturday at the Endocrine Society's 99th annual meeting, ENDO 2017, in Orlando, Fla.

2 Apr 2017

BPS shows potential for increasing aggressiveness of breast cancer, study finds

Bisphenol S (BPS), a substitute for the chemical bisphenol A (BPA) in the plastic industry, shows the potential for increasing the aggressiveness of breast cancer through its behavior as an endocrine-disrupting chemical, a new study finds.

2 Apr 2017

AAPM releases statement calling on Congress to oppose NIH funding cuts

The American Association of Physicists in Medicine, a professional nonprofit organization supporting medical physicists, has released a statement calling on Congress to reverse President Trump's proposed cuts to FY 2018 funding for the National Institutes of Health.

31 Mar 2017

Occupational exposure to biocides associated with higher risk of thyroid cancer

Workers exposed to chemicals like deodorizers, sanitizers, disinfectants and sterilizers on the job may be more likely than other people to develop thyroid cancer, a recent study suggests.

31 Mar 2017

Study provides new understanding of molecular mechanisms of HPV-induced tumors

The incidence of human papillomavirus (HPV)-associated (HPV+) head and neck squamous cell carcinoma (HNSCC) of the oropharynx has dramatically increased over the last decade and is now more frequently diagnosed than uterine cervical cancer in the United States.

31 Mar 2017

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

Bayer today announced positive data on its investigational compound copanlisib, an intravenous pan-Class I phosphatidylinositol-3-kinase (PI3K) inhibitor with predominant inhibitory activity against PI3K-α and PI3K-δ isoforms.

31 Mar 2017

Northwestern Memorial first in Illinois to integrate combined MR-PET scanner into health care system

Northwestern Memorial Hospital is now home to the Chicago area's first combined magnetic resonance and positron emission tomography scanner, a machine that shortens the total time a patient spends in imaging tests while providing exceptional image quality at lower doses of radiation.

31 Mar 2017

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

QIAGEN N.V. today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer.

From QIAGEN Manchester Limited 31 Mar 2017

New report highlights need for rapid research progress and improved outcomes in pancreatic cancer

The new report highlighting trends in cancer released today by the American Cancer Society, the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI) points to the urgent need for more research and funding in pancreatic cancer.

31 Mar 2017

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Novocure announced today results from the second cohort of its phase 2 pilot PANOVA trial studying Tumor Treating Fields (TTFields) in combination with nab-paclitaxel and gemcitabine for the treatment of advanced pancreatic cancer.

31 Mar 2017

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Novocure announced today results from its phase 2 pilot INNOVATE trial studying Tumor Treating Fields (TTFields) in combination with weekly paclitaxel for the treatment of recurrent ovarian cancer.

31 Mar 2017

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

Case Western Reserve University and Q2 Pharma Ltd., an Israeli biopharmaceutical company, have signed a two-year option to license small molecule, antivirulence technology to potentially treat bacterial infections such as methicillin-resistant staphylococcus aureus (MRSA), the first known scientific effort of its kind.

31 Mar 2017

Cancer News and Research

Latest Cancer News and Research

Researchers shed light on how immune cells weaken with age

RCR: NHS delivery plans fail to tackle early diagnosis, treatment of cancer

Patients' immune system profiles could be linked to effectiveness of cancer immunotherapy

New gene-based blood tests can reliably detect previously unidentifiable forms of skin cancer

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Cow's milk decreases the body's ability to absorb oral thyroid hormone medication

Pyrethroid pesticide exposure may cause earlier sexual maturity in boys

Exposure to flame retardants may be linked to papillary thyroid cancer risk

BPS shows potential for increasing aggressiveness of breast cancer, study finds

AAPM releases statement calling on Congress to oppose NIH funding cuts

Occupational exposure to biocides associated with higher risk of thyroid cancer

Study provides new understanding of molecular mechanisms of HPV-induced tumors

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

Northwestern Memorial first in Illinois to integrate combined MR-PET scanner into health care system

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

New report highlights need for rapid research progress and improved outcomes in pancreatic cancer

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in